Jellison William R bought ANIK

June 3, 2024 · Form 4 insider transaction

Jellison William R bought 468 shares of Anika Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Acquired (buy-side)
Shares
468
Price
$0.00
Total value
N/A
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJune 3, 2024
Filing dateJune 5, 2024
Shares owned after3,168
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

These shares represent restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in full on the earlier of the next annual meeting of the Company's stockholders or June 3, 2025.

View the original Form 4 on SEC EDGAR